GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2651 - 2675 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 2 15 mild
G49916XD
99
IgM Patient 2 15 mild
G68461PT
99
IgM Patient 1 6 moderate
G39023AU
99
IgM Patient 3 -180 mild
G09482NW
99
IgM Patient 3 -180 mild
G78255UI
99
IgG Patient 3 11 mild
G21460SG
99
IgM Patient 3 11 mild
G72739GY
99
IgG Patient 4 12 mild
G32699RJ
99
IgM Patient 4 12 mild
G14569AR
99
IgM Patient 1 22 moderate
G98068PA
98
IgG Patient 2 15 mild
G54064FW
98
IgM Patient 2 15 mild
G14844CX
98
IgM Patient 2 24 mild
G62826CL
98
IgM Patient 2 3 mild
G37036SF
98
IgM Patient 3 11 mild
G25407RZ
98
IgM Patient 3 4 mild
G39213VZ
98
IgG Patient 4 12 mild
G28868ZC
98
IgG Patient 4 12 mild
G58547FH
98
IgG Patient 4 12 mild
G86566MF
98
IgG Patient 2 24 mild
G10133VD
97
IgG Patient 3 11 mild
G52880ZN
97
IgG Patient 3 4 mild
G52880ZN
97
IgM Patient 3 11 mild
G32611KT
97
IgM Patient 3 4 mild
G25407RZ
97
IgG Patient 4 12 mild
G94435QH
97

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024